Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluation of CG-100 Intraluminal Bypass device
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CG-100 Intraluminal Bypass Device | Experimental | Subjects will be treated with CG-100 Intraluminal Bypass Device |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CG-100 Intraluminal Bypass Device | Device | Subjects will be treated with the CG-100 Intraluminal Bypass Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Safety of the CG-100 Intraluminal Bypass Device | Assessment of Serious Adverse Events | 10 days |
| Measure | Description | Time Frame |
|---|---|---|
| Safety of the CG-100 Intraluminal Bypass Device | Assessment of Serious Adverse Events | 4 weeks |
Not provided
Inclusion Criteria (pre-operative):
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Soroka Medical Center | Rehovot | Israel |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |